Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning Grants - Priority Announcement: Health Services and Policy Research

University of British Columbia

$24,997.00

Planning the Evaluation of Medication Review in Emergency Department Patients

EF 2011-12

Résumé
The act of prescribing pharmaceuticals is the most common medical intervention performed by physicians, and a cornerstone of disease prevention and treatment. Not surprisingly, expenditures for prescription and over-the-counter medications have become the fastest growing category of health care spending in Canada, and totaled over $31 billion in 2010. Presently, over 70% of Canadians age 65 years and older use at least one prescribed medication daily. Such widespread use of medications may offer significant health benefits, but may also be harmful. Adverse drug events, harmful and unintended events related to medication use, cause over 1.7 million emergency department (ED) visits in Canada each year, and are a leading cause of hospital admission. Yet, many adverse drug events are not identified by physicians in community settings or in hospitals, leading to patients being re-prescribed the same medications and experiencing recurrent serious adverse drug events. This cycle is dangerous and wasteful. In order to reduce drug-related morbidity, interventions to identify adverse drug events in the ED setting and to notify community-based practitioners of serious adverse drug events need to be evaluated. Our team has four objectives: (i) to develop a research agenda on patients presenting to the ED with adverse drug events, (ii) to build consensus around methodological challenges inherent in research on adverse drug events in the ED setting, (iii) to develop a framework for evaluating the effect of ED-based medication review on adverse drug event identification and patient outcomes, and (iv) to propose strategies for communicating adverse drug event information to community-based practice settings.
Programme
Planning Grants - Priority Announcement: Health Services and Policy Research
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
257953
Name
Hohl Corinne M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Planning Grants
Projecttitle
Planning the Evaluation of Medication Review in Emergency Department Patients
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$24,997
Cihrequipment2
$0
Programname2
Planning Grants - Priority Announcement: Health Services and Policy Research
Keyworddelim
Adverse Drug Events; Community-Based Primary Healthcare; Drug Safety And Effectiveness; Emergency Medicine; Medication Review; Planning; Team Building
Abstract
The act of prescribing pharmaceuticals is the most common medical intervention performed by physicians, and a cornerstone of disease prevention and treatment. Not surprisingly, expenditures for prescription and over-the-counter medications have become the fastest growing category of health care spending in Canada, and totaled over $31 billion in 2010. Presently, over 70% of Canadians age 65 years and older use at least one prescribed medication daily. Such widespread use of medications may offer significant health benefits, but may also be harmful. Adverse drug events, harmful and unintended events related to medication use, cause over 1.7 million emergency department (ED) visits in Canada each year, and are a leading cause of hospital admission. Yet, many adverse drug events are not identified by physicians in community settings or in hospitals, leading to patients being re-prescribed the same medications and experiencing recurrent serious adverse drug events. This cycle is dangerous and wasteful. In order to reduce drug-related morbidity, interventions to identify adverse drug events in the ED setting and to notify community-based practitioners of serious adverse drug events need to be evaluated. Our team has four objectives: (i) to develop a research agenda on patients presenting to the ED with adverse drug events, (ii) to build consensus around methodological challenges inherent in research on adverse drug events in the ED setting, (iii) to develop a framework for evaluating the effect of ED-based medication review on adverse drug event identification and patient outcomes, and (iv) to propose strategies for communicating adverse drug event information to community-based practice settings.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hohl, Corinne M; Lexchin, Joel; Sobolev, Boris G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $24,997~ $0~